First generic version of Glaxo Wellcome's antidepressant is launched at a 10% discount to the brand ($72.08 for 100-count 75 mg tablets and $96.16 for 100-count 100 mg tablets). Teva's ANDA was approved Nov. 29 following a Nov. 19 settlement of patent litigation brought by Glaxo. The settlement involved a license to Teva to manufacture its own version of the product. Glaxo has also settled litigation with Watson over the product
You may also be interested in...
The award of Glaxo's bupropion franchise to Grey Advertising consolidates six of the firm's nine DTC-advertised products into one agency.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011